Jean Louis Jouve

Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab

Anthony Dohan, B. Gallix, Boris Guiu et al. · Gut · 2019 · 138 citations

Medicine, Oncology, Radiology +17

Trends in incidence and management of gallbladder carcinoma

Sylvain Manfrédi, Anne Marie Benhamiche, Nicolás Isambert et al. · Cancer · 2000 · 64 citations · Full text

Medicine, Oncology, Surgery +17

Phase III trial of chemotherapy with or without irinotecan in the front-line treatment of metastatic colorectal cancer in elderly patients (FFCD 2001–02 trial). Results of a planned interim analysis

Emmanuel Mitry, Jean–Marc Phelip, Franck Bonnetain et al. · Critical Reviews in Oncology/Hematology · 2008 · 29 citations

Medicine, Oncology, Pharmacology +10

Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study

François Ghiringhelli, Julie Vincent, Leila Bengrine et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis

Jean Michel Petit, Samia Hamza, Fabien Rollot et al. · Acta Diabetologica · 2013 · 21 citations

Medicine, Endocrinology, Internal Medicine +16